David Laybutt

Associate Professor David Laybutt is affiliated with the University of Sydney’s Faculty of Medicine and Health and the Westmead Institute for Medical Research. His research focuses on molecular mechanisms in type 2 diabetes pathogenesis, specifically pancreatic beta cell dysfunction.

Research interests span:

• Diabetes
• Beta Cell Biology
• Endocrinology
• Molecular Biology
• Cellular Stress Response
• Unfolded Protein Response

His recent grant activity includes:

• 2022: ‘Type 2 diabetes relief by UPR-mediated beta cell protection’ (NHMRC Ideas Grant)
• 2021: ‘XBP1 maintains beta-cell identity by repressing an alpha-cell program’ (Diabetes Australia Research Trust)